BioSpace News Archive

Urotronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Optilume® Urethral Drug Coated Balloon for use in male urethral strictures.

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the peer reviewed publication of Phase 3 clinical data in Muscle and Nerve.

Biohaven Pharmaceutical Holding Company Ltd. announced today that NURTEC ODT (rimegepant) 75 mg was approved by the Ministry of Health of Israel for the preventive treatment of episodic migraine in adults.

Nevro Corp. today announced that three abstracts for Painful Diabetic Neuropathy (PDN) and Non-Surgical Refractory Back Pain (NSRBP) were accepted for podium presentation at the 2022 North American Neuromodulation Society Annual Meeting (NANS 2022) and will be presented during the late-breaking plenary sessions on January 15, 2022.

Year-end net profit of $23.5 million or $0.91 per share which includes net income from the sale of the AquaGuard operations.

Catamaran Bio , Inc. today announced preclinical data that demonstrate key capabilities of its TAILWINDTM platform being applied to develop CAT-248, an allogeneic CD70-targeted CAR-NK cell therapy.

Bristol Myers Squibb (NYSE: BMY) today announced that on December 10, 2021, its Board of Directors approved an increase in the quarterly dividend and authorized an additional multi-year share repurchase program.

Mednow Inc. is pleased to announce that further to its press release dated November 18, 2021, it has closed the acquisition of Infusicare Canada Inc. (“ Infusicare ”) for a cash payment of C$1.85M.

BELLUS Health Inc. today announced that the 50 mg and 200 mg BID doses of BLU-5937 in its Phase 2b SOOTHE trial for the treatment of RCC achieved statistical significance on the primary endpoint with 34% placebo-adjusted reduction in 24-hour cough frequency observed (p ≤ 0.005) at day 28.

HCW Biologics Inc. announced today Hing C. Wong, Ph.D., Founder and CEO of HCW Biologics, was named the 2021 Weaver H. Gaines Entrepreneur of the Year by BioFlorida.